Indeed, mutually complementary Q-PCR, Western blot and immunohistochemical analyses revealed that the expression of RasGRP3 and the active phosphoRasGRP3 are elevated in numerous human breast tumor samples as well as in multiple breast derived ductal adenocarcinoma cell lines. The gene discussed is RASGRP3; the disease is invasive ductal breast carcinoma.